Thursday, November 19

Prostate cancer is the second leading cause of cancer deaths in men, so you’d think doctors would be adamant about screening guys for it. Yet for years, prostate cancer screening via the PSA (prostate-specific antigen) test has been plagued by vague recommendations, and some back-and-forth messaging that flipped between “get it” and “the benefits might not be worth it.” Until recently, organizations including the American Cancer Society (ACS) used to give a recommendation that at age 50, guys should talk with their doctors about screening, then engage in a process of “shared decision-making” about whether to get the test.

Many guys didn’t know whether they should get it or not. Without a clear recommendation, it was easy for some to think this PSA blood test wasn’t very important to do at all. The landscape has changed.

The American Cancer Society just came out with new guidelines that for the first time, unequivocally say that men should get the screening test. Guys at average risk should start at age 50. Guys at higher risk (more on that later) should start at 45.

Why that’s a big deal: “The new guideline not only gets rid of shared decision-making, which is really difficult to execute, is subject to bias, and is really time-intensive,” says Yaw Nyame, MD, of the Fred Hutchinson Cancer Center at the University of Washington Medical Center. “But it couples that with a better understanding of what present-day prostate cancer screening is.”

Today, the PSA test is “just the first step, not the final answer,” says William Dahut, MD, chief scientific officer at ACS, and a contributing author to the guidelines. “It is a simple blood test, and an elevated result does not automatically mean cancer of the need for a biopsy.” Many more tools including MRIs and biomarkers help physicians drill down on who needs additional testing. “Our goal is to find prostate cancer earlier, while avoiding unnecessary procedures and treatment,” Dr. Dahut adds.

What changed that prompted the revised recommendations? “It’s important to understand that guidance evolves as the evidence does,” says Dr. Dahut. Research has piled up to indicate that PSA screening reduces prostate cancer deaths.

“We do not need to make a disclaimer that maybe you should, maybe you shouldn’t do it. Everyone should do it and you should start early, especially if you have a higher risk of cancer,” says Dr. Nyame, who was on the expert panel that reviewed the new ACS screening guidelines.

What the New Guidelines Are

While all men should get the test, according to the new guidelines, it’s not a “one size fits all” screening recommendation, Dr. Nyame explains. Recommendations vary according to risk. Find your category and screen according to that.

These are the new ACS guidelines for who and when:

  • Average-risk men, ages 50-69: PSA screening every two years.
  • Black men, ages 45-69: Annual screening (also note the earlier start date) Black men have a higher incidence of prostate cancer and have double the mortality compared to white men.
  • Non-Black men with a strong family history: ages 45-69: Annual screening. A strong family history includes a father, brother, or son diagnosed before age 65 or more than one close relative diagnosed at any age.
  • Men 70-74: Individualized decision-making, since the balance of benefits and harms remains uncertain.
  • Men 75+ with a life expectancy under 10 years: Screening not recommended.

Other prostate screening guidelines came out earlier in 2026 from the American Urological Association (AUA) and the Society for Urologic Oncology (SUO) that had slightly different recommendations for the age at which you should start screening. What gives? The difference in recommended age and frequency of screening “has to do with how the guideline creators are viewing the different studies that they’re using to support their decision making,” Dr. Nyame says.

It doesn’t mean guys should throw up their hands and do nothing in frustration. “The AUA/SUO and ACS guidelines recognize the benefit of knowing a PSA test result earlier in life. A PSA test in the 40- to 50-year age range is a good predictor of the likelihood someone has or will develop a clinically significant prostate cancer,” says James A. Eastham, MD, chief of the urology service, Memorial Sloan Kettering Cancer Center. A higher level early in life is a strong signal that you need to be really diligent about checking your PSA.

“We’ve watched prostate cancer incidence increase—especially metastatic cancer, for over a decade now,” says Dr. Nyame. “And to know that we have a guideline that is so action-oriented toward reversing that course is really exciting.”

Marty Munson, currently the health director of Men’s Health, has been a health editor at properties including Marie Claire, Prevention, Shape and RealAge. She’s also certified as a swim and triathlon coach.

Read More

Share.
Leave A Reply

Exit mobile version